Nothing to see here, Lilly wins in kicking out Genentech's Talz progeny patent (for now) By Dr Rose Hughes on Wednesday, February 26, 2020 added matter anti-IL-17 Eli Lilly v Genentech Genentech insufficiency ixekizumab Lilly patents plausibility Rose Hughes Second medical use SPC Taltz Warner-Lambert +
Takeda v Roche: "Is it plausible? Is it true?" By Dr Rose Hughes on Thursday, August 01, 2019 biologics biosimilars Entyvio insufficiency monoclonal antibody mr justice birss patents plausibility Roche Second medical use takeda Vedolizumab Warner-Lambert +
Fordham 27 (Report 8): Second Medical Use/Plausibility By Annsley Merelle Ward on Sunday, April 28, 2019 #IPKat AmeriKat event report fordham 2019 implausibly industrial applicability plausibility second medical indication Second medical use Warner-Lambert +
BREAKING: Mr Justice Arnold finds Genentech's anti-IL-17 patent and SPC application invalid, but not without a CJEU reference first By Dr Rose Hughes on Friday, March 01, 2019 anti-IL-17 Genentech insufficiency ixekizumab Lilly plausibility Second medical use SPC Taltz third party authorization Warner-Lambert +
Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 By Dr Rose Hughes on Wednesday, January 09, 2019 actavis ibil lyrica patents plausibility Second medical use swiss form claim Warner-Lambert +
Never Too Late: if you missed the IPKat last week! By Dr Rose Hughes on Wednesday, December 19, 2018 draft Directive on copyright in the Digital Single Market; architecture generic mark internet trolls Marrakesh Treaty patent trolls unregistered design right Warner-Lambert +